Targeted long-read sequencing identifies missing pathogenic variant in unsolved 11β-hydroxylase deficiency

Jidong Liu,Huihui Tian,Xinchen Jin,Yanxiang Wang,Zhenhong Zhang,Mengxue Li,Lulu Dai,Xiaoli Zhang,Ling Jiang
DOI: https://doi.org/10.1186/s12902-024-01748-5
2024-10-16
BMC Endocrine Disorders
Abstract:11β-hydroxylase deficiency (11β-OHD), caused by homozygosity or compound heterozygosity CYP11B1 variants, is the second most common cause of congenital adrenal hyperplasia (CAH). Due to the high degree of sequence identity between CYP11B1 and CYP11B2 , chimeric genes, and complex structural variants (SVs), the conventional approach to gene testing for 11β-OHD is facing challenges. The study aimed to clarify the underlying genetic causes of two siblings of a Chinese family with 11β-OHD.
endocrinology & metabolism
What problem does this paper attempt to address?